Q&A with Scott Soefje, PharmD, MBA, BCOP, FCCP
This is part 2 of a two-part series on IV workflow management. Part 1, presented in PP&P’s March 2017 IV Safety Supplement, discussed increasing safety in IV compounding, while part 2, presented here, addresses overcoming challenges in IV workflow software implementation.
PP&P: How should an organization develop an IV workflow software rollout strategy?
Scott Soefje: The University Medical Center Brackenridge IV workflow system rollout is occurring in stages. We determined that the software would be most beneficial for high-risk drugs, so it was implemented first in the cancer clinic. Six chemotherapy agents were initially added to the software; additional drugs are then added each week until all medications used in the clinic are prepared via the IV workflow system. Once that is achieved, the software will be implemented in the inpatient hospital and then in other oncology areas throughout the network. Thereafter, we will target the non-oncology drugs within the hospital at one site, and roll out this process throughout the network.
PP&P: What challenges should organizations be aware of when implementing IV workflow software?
Soefje: Several issues should be top of mind throughout the IV workflow software implementation process, including interfacing the software to the EMR, configuring gravimetric weighing, stacking NDC numbers, setting aside sufficient space for the computer and related equipment, and making time to enter NDC codes into the system.
PP&P: What benefits has the hospital realized as a result of implementing IV workflow automation?
Soefje: Although we are still in the early stages of our implementation, we have already realized significant benefits, including time savings, standardization of IV processes, and increased assurance that the medications provided to patients have been accurately compounded.
PP&P: What are your future goals for utilizing IV workflow software?
Soefje: Our immediate goal is to continue to roll out the system throughout the entire network, with the ultimate goal of compounding every drug in the pharmacy using the IV workflow system. In addition, we aim to develop a process that allows any pharmacist in the network to check IVs; thus, we could assist other sites on busy days. Moreover, we would like to utilize the software to evaluate workload statistics for IVs used throughout the health system. Lastly, the system could be used to decentralize pharmacists from the central pharmacy, increasing face time with patients.
Scott Soefje, PharmD, MBA, BCOP, FCCP, is the director of pharmacy at the Dell Seton Medical Center at The University of Texas at Austin. He is the immediate past-president of the Hematology/Oncology Pharmacy Association (HOPA). Scott earned his Bachelors Degree in pharmacy from The University of Texas at Austin and his PharmD from the combined program at The University of Texas Health Sciences Center at San Antonio and The University of Texas at Austin. He is board-certified in oncology pharmacy and recently earned an MBA from George Washington University.
Enter our Sweepstakes now for your chance to win the following prizes:
Just answer the following quick question for your chance to win:
Entries are limited to one entry per person in any active sweepstakes.
Thank you for your entry.